BioCryst Pharmaceuticals Inc. (BCRX)
NASDAQ · Healthcare
BioCryst Pharmaceuticals Inc. Total Liabilities 2009–2025
BioCryst Pharmaceuticals Inc. annual total liabilities history from 2010 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- BioCryst Pharmaceuticals Inc. total liabilities as of December 31, 2025: 633.3M, a 34.46% decrease year-over-year.
- BioCryst Pharmaceuticals Inc. total liabilities for 2025 were 633.3M, a 34.46% decrease from 2024.
- BioCryst Pharmaceuticals Inc. total liabilities for 2024 were 966.4M, a 0.63% decrease from 2023.
- BioCryst Pharmaceuticals Inc. total liabilities for 2023 were 972.5M, a 15.14% increase from 2022.
- BioCryst Pharmaceuticals Inc. total liabilities for 2022 were 844.6M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| BioCryst Pharmaceuticals Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $633 |
| 2024 | $966 |
| 2023 | $972 |
| 2022 | $845 |
| 2021 | $695 |
| 2020 | $354 |
| 2019 | $137 |
| 2018 | $98 |
| 2017 | $94 |
| 2016 | $88 |
| 2015 | $75 |
| 2014 | $61 |
| 2013 | $50 |
| 2012 | $58 |
| 2011 | $67 |
BioCryst Pharmaceuticals Inc. Total Liabilities — FAQ
BioCryst Pharmaceuticals Inc. (BCRX) total liabilities over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BCRX's total liabilities history?
The chart and table above show BioCryst Pharmaceuticals Inc.'s total liabilities by year and by quarter, including the growth rate.